Entrepreneur First — 2024 Investments
3 investments dated 2024 · listed companies and verified rows first · show all
Revalia Bio conducts human organ research through its Human Data Trials platform, combining AI, hardware, and software to study human organs.
AI & Machine LearningBiotechDeep TechHealthtechNew Haven, US
Greg Tietjen(Co-Founder & Chief Executive Officer)inJenna DiRito(Co-Founder & Chief Operating Officer)Kourosh Saeb-Parsy(Co-Founder & Advisor)Helen Hughes(Co-Founder & Chief People Officer)Peter Buniak(Co-Founder & Advisor)Jenna DiRito, PhD(Founder)in
Board seatMilad Alucozai· per SEC Form D · $17M raise · filed Nov 2024
Co-investorsAmerica's Frontier FundConnecticut InnovationsDniproSierra VenturesBoxOne Ventures
Level Zero Health develops electrochemical and microfluidic biosensor platforms for point-of-care and continuous diagnostic devices.
BiotechHealthtechMedical DevicesDover, US
Ula Rustamova(CEO)inIrene Jia(CTO)inUlviyya Rustamova(Executive Officer, Director)Yiran Jia(Director)
BoardPhilip Kneis(Director)in
Co-investorsAnorak VenturesBlack Jays VenturesSamos InvestmentsSOSVTranspose Platform ManagementUnruly Capital+1 more
Tuza is a banking automation platform that orchestrates AI agents alongside human colleagues and customers to automate manual processes in pricing, data quality, and customer onboarding.
AI & Machine LearningFintechSaaSLondon, GB
Ed Hardy(CEO)inOlivia Stannah(CTO)in
Co-investorsNorthzone
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.